Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Oklahoma reconsidering Medicaid expansion

Republican leaders argue Medicaid "rebalancing" isn't the same as what was initially offered under the Affordable Care Act.

Report: Insurers’ losses on ACA exchanges don’t amount to ‘death spiral’

The majority of insurance companies offering individual health coverage on the Affordable Care Act’s exchanges lost money on those plans in 2015, according to a new McKinsey & Co. report.

'Big Data' in the healthcare estimated to top $34B by 2022

The "Global Big Data in Healthcare - Estimates & Forecast, 2015-2022" from Research and Markets estimates the healthcare sector is estimated to grow by $34B by 2022.

GE Healthcare CEO aims to grow from within

John Flannery built a reputation as a prolific rainmaker in his previous role as head of business development at General Electric Co., logging more than $26 billion in deals, yet acquisitions are far from his mind as chief executive of the U.S. conglomerate’s healthcare unit.

St. David’s HealthCare to invest $275M in Texas

St. David’s HealthCare announced plans to invest $275 million into the Central Texas healthcare infrastructure during the next two years, reports Community Impact.

Wellmark raising exchange premiums up to 43 percent in Iowa

The insurer covers more than 30,000 Iowans through the exchange, representing about about 75 percent of all individual policies in Iowa's market. 

Work-life balance? 13 of the best healthcare companies in the U.S.

Business Insider takes a look at 13 healthcare companies that pay well and emphasize employee happiness.

Ex-HHS official: HIPAA must keep up with mobile health

The federal regulatory environment has not kept pace with the progress of mobile health, which is driven by consumers who expect to have all sorts of information, including health data, on their phones, said Jeffrey Dunifon, an associate attorney at Baker & Mckenzie who previously was an investigator at the Department of Health and Human Services Office for Civil Rights.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.